San Donato Hospital
Pediatric oncology in Italy typically costs between $46,300 and $153,800. Final expenses depend on the type of malignancy, the complexity of the treatment protocol, and the length of hospital stay. International patients can often find savings of 30-50% compared to equivalent private treatments in the US.
Typical Pediatric Oncology Costs in Italy
Major hubs for pediatric oncology include Milan and Rome, where specialized research institutes are concentrated. While treatment in Milan is often slightly lower, costs can vary by approximately 4-6% between these cities. Consult with a specialist to get accurate pricing for your child's specific medical needs.
| Italia | España | Turquía | |
| Tratamiento complejo del sarcoma de Ewing | de $40,000 | de $35,000 | de $30,000 |
| Tratamiento complejo del neuroblastoma | de $50,000 | de $70,000 | de $28,000 |
| Trasplante de médula ósea | de $95,000 | de $71,782 | de $36,000 |
| Trasplante autólogo de médula ósea | de $90,000 | de $40,000 | de $31,500 |
| Trasplante alogénico de médula ósea de un donante no emparentado | de $150,000 | de $150,000 | de $80,000 |
Bookimed no añade cargos extra a los precios de los tratamientos de Oncología pediátrica. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Oncología pediátrica y tienen las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después del tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de procedimientos de Oncología pediátrica.
Pionero en terapia génica para inmunodeficiencias pediátricas: el Dr. Aiuti dirige la investigación en el Hospital San Raffaele con ensayos respaldados por la UE.
Italy hosts globally recognized pediatric oncology centers specializing in advanced gene therapy and hematopoietic treatments. Top-rated facilities include San Raffaele in Milan, which pioneered the world's first stem cell therapy for ADA-SCID. These centers combine intensive research with clinical care under IRCCS accreditation.
Bookimed Expert Insight: Data shows a strong correlation between research activity and patient outcomes in Milan. IRCCS-accredited clinics like San Raffaele integrate lab research directly into bedside care. This structure allows pediatric patients to access experimental gene therapies not available in standard regional hospitals.
Patient Consensus: Parents note that traveling to northern specialized centers is often necessary for complex cases requiring multidisciplinary teams. Families emphasize checking for English-speaking staff to reduce stress during long-term treatment protocols.
Italy uses the Italian Association of Pediatric Hematology and Oncology (AIEOP) to standardize childhood cancer care. This network includes 50 specialized centers following unified diagnostic protocols. While AIEOP coordinates clinical trials and treatment standards, regional resource disparities persist between Northern and Southern Italy.
Bookimed Expert Insight: Quality of care in Italy often correlates with a clinic's research status. Hospitals like San Raffaele are designated as IRCCS, meaning they must legally combine clinical care with active scientific research. Data shows these institutions handle over 300,000 patients annually. Choosing an IRCCS facility typically ensures access to the latest international protocols before they reach general local hospitals.
Patient Consensus: Parents note that while protocols are technically standardized, the speed of diagnosis and access to newer technology vary by region. Many families recommend seeking a second opinion at a major northern hub if your local hospital lacks specialized pediatric oncology infrastructure.
Italy offers active clinical trials for difficult-to-treat pediatric cancers including high-risk neuroblastoma and relapsed leukemia. Specialized centers like San Raffaele in Milan conduct advanced research in gene therapy. These programs follow European protocols to provide innovative treatments for refractory and rare pediatric cases.
Bookimed Expert Insight: Clinics with IRCCS status, like San Raffaele, integrate research directly into patient care. This status is only granted to few institutions by the Italian Ministry of Health. Patients at these centers often gain faster access to gene therapy and stem cell protocols. This link between research and clinic ensures updated treatment standards for rare conditions.
Patient Consensus: Patients note it is vital to contact AIEOP-affiliated hospitals directly with pathology reports. Many families emphasize preparing for regional travel as specific trial slots for difficult cases fill quickly.
Pediatric oncology follow-up in Italy transitions children from active treatment to long-term wellness monitoring. Programs focus on recurrence detection, managing late effects, and psychosocial support. Specialized centers like San Raffaele in Milan provide systematic screenings. These include cardiac imaging, endocrine assessments, and personalized survivorship plans.
Bookimed Expert Insight: Italian research hospitals like San Raffaele often lead in specialized follow-up due to high surgical volumes. They perform over 52,000 operations annually. This experience allows doctors like Dr. Alessandro Aiuti to create precise monitoring protocols for rare conditions. Families should prioritize centers with IRCCS accreditation for the most standardized survivorship data.
Patient Consensus: Parents note that getting a written treatment summary is vital for future health. They often find that Northern Italian centers offer more organized coordination with local pediatricians than other regions.
Most Italian pediatric oncology centers allow one parent to stay overnight with their child. This practice supports family-centered care and significantly reduces patient anxiety during intensive treatments. Facilities like San Raffaele provide bedside cots or pull-out beds for a parent to remain present 24/7.
Bookimed Expert Insight: Italian research hospitals with IRCCS accreditation, such as San Raffaele, integrate clinical care with advanced research. Our data indicates these centers prioritize rooming-in specifically for complex cases like gene therapy. This ensures parents are present for medical rounds and immediate post-procedure monitoring.
Patient Consensus: Parents note that having a bed right next to their child makes a huge difference during chemotherapy. They suggest bringing a personal pillow since hospital cots are often quite basic.